We have some exciting news to share!
We’re thrilled to announce that Shaare Zedek Medical Center in Jerusalem has taken a giant leap forward in the field of medical research.
In collaboration with SOPHiA GENETICS, a leader in data-driven medicine, we are now live on the SOPHiA DDM™ Platform. This platform will allow us to advance our research regarding treatment of myeloid disorders and contribute to the development of precision medicine as we as stay up to date with international recommendations to better serve our community.
Myeloid disorders impact millions globally, and the complexities of these genetic mutations require timely, cost-effective, and reliable sequencing strategies.
Molecular profiling through next-generation sequencing (NGS) plays a pivotal role in understanding myeloid malignancies, but the data can be overwhelming. The SOPHiA DDM™ Platform, powered by artificial intelligence (AI), efficiently analyzes, and interprets complex NGS data, providing streamlined insights within days.
Not only does it accelerate analysis and insights, but it also ensures reproducible data, supporting our research team’s expertise growth.
We’re excited about the possibilities this collaboration brings to the field of medicine and are dedicated to pushing the boundaries of medical research and continuing to save, deliver, and change lives.
